Autonomous Discovery
Anthropic says its AI Claude has autonomously discovered a new enzyme system similar to machinery behind the powerful gene-editing tool Crispr. It is the first result from Anthropic’s newly launched wet lab and an early test of Claude’s usefulness for science as the company prepares to go public.
Anthropic’s biolab made a discovery it’s comparing to Crispr
It took nearly 1,000 Claude agents 21 hours and 210 million tokens to uncover the novel enzyme system.
The company states that Claude found the enzyme system after searching through a massive database of DNA sequences, adding that its scientists’ involvement was limited to the initial prompt and lab work.
Process and Validation
Over 21 hours, Anthropic said nearly 950 Claude agents worked through 210 million tokens before one spotted an unusual repeating pattern in the dataset and flagged it for human review. Further analysis and lab testing revealed a previously uncharacterized enzyme system found in bacteriophages, a type of virus that infects bacteria.
Anthropic said it is still working to understand what the enzyme system does, but noted it felt it was important to share such findings early to demonstrate Claude’s capabilities and to give the broader community insight into ongoing research.
Practical Impact
Despite Anthropic’s comparisons to Crispr, it remains unclear whether the discovery will have practical applications or match the transformative impact of gene-editing technology. The announcement arrives as Anthropic seeks to attract more scientists to its lab and expand into areas like drug discovery.
The push comes as artificial intelligence companies increasingly turn to scientific research to demonstrate the value of their models. Competitors like OpenAI have also targeted advanced mathematical problems as part of broader capability demonstrations.
